SCHEMBL19734

SCHEMBL19734

CCCCOS(=O)(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27206830 0.97 CA1 (0.56)
Phosphine SCHEMBL27878832 0.97 CA1 (0.56)
SCHEMBL27918238 0.97 CA1 (0.56)
SCHEMBL193291 0.97 CA1 (0.56)
Ammonia Solution, Strong SCHEMBL635964 0.97 CA1 (0.56)
Phosphine SCHEMBL3823811 0.97 CA1 (0.56)
Ethane SCHEMBL28406834 0.97 CA1 (0.56)
SCHEMBL17456625 0.97 CA1 (0.56)
SCHEMBL17456495 0.97 CA1 (0.56)
SCHEMBL27424529 0.97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 12737 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260130856-A1 LIPOSOME COMPOSITIONS FOR DELIVERY OF COMPOUNDS AND METHODS THEREOF NANOTECH PHARMA INC (US) 2026-05-14 US claimed
US-20260124148-A1 POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY BHAMIS RES LABORATORY PVT LTD (IN) 2026-05-07 US claimed
EP-4593865-B1 PHARMACEUTICAL COMPOSITION COMPRISING NFL-TBS40-63 PEPTIDE, VARIANTS OR SALTS THEREOF AND ALANINE GLIOCURE (FR) 2026-05-06 EP claimed
US-12616694-B2 Pharmaceutical compositions for subcutaneous administration of levosimendan TENAX THERAPEUTICS, INC. (US) 2026-05-05 US claimed
WO-2026089754-A1 COMPOSITIONS AND METHODS FOR INTRANASAL DELIVERY OF THERAPEUTIC PEPTIDES Finitus, LLC (US) 2026-04-30 WO claimed
WO-2026089751-A1 COMPOSITIONS AND METHODS FOR MICROSPHERE DELIVERY OF CARNOSINE FOR TREATMENT OF NEURODEGENERATIVE DISEASES AND DISORDERS Finitus, LLC (US) 2026-04-30 WO claimed
WO-2026089752-A1 COMPOSITIONS AND METHODS FOR MICROSPHERE DELIVERY OF THERAPEUTIC PEPTIDES Finitus, LLC (US) 2026-04-30 WO claimed
WO-2026090260-A1 STABLE ORAL LIQUID COMPOSITIONS Method Pharmaceuticals, LLC (US) 2026-04-30 WO claimed
US-20260108460-A1 STABLE ORAL LIQUID COMPOSITIONS METHOD PHARMACEUTICALS LLC (US) 2026-04-23 US claimed
US-20260108467-A1 COMPOSITIONS AND METHODS FOR MICROSPHERE DELIVERY OF THERAPEUTIC PEPTIDES FINITUS LLC (US) 2026-04-23 US claimed
WO-2000015262-A1 DRY POWDER ACTIVE AGENT PULMONARY DELIVERY INHALE THERAPEUTIC SYSTEMS, INC. (US) 2000-03-23 WO claimed
WO-1999042111-A1 HIGH-ENERGY CYCLODEXTRIN COMPLEXES CYCLOPS, EHF. (IS) 1999-08-26 WO claimed
EP-0694524-B1 Process for the preparation of butyle acrylate by direct esterification ATOCHEM ELF SA (FR) 1997-10-15 EP claimed
US-5606102-A SOLVENT-FREE; USING SULFURIC ACID CATALYST ELF ATOCHEM S.A. (FR) 1997-02-25 US claimed
CN-1125219-A Process for the manufacture of butyl acrylate by direct esterification ATOCHEM ELF SA (FR) 1996-06-26 CN claimed
US-5403963-A Process for the production of lower alcohols SHELL OIL COMPANY (US) 1995-04-04 US claimed
EP-0376303-A2 Organic sulfur-containing compounds as adjuvants for positive electrostatic liquid developers E.I. DU PONT DE NEMOURS AND COMPANY (US) 1990-07-04 EP claimed
US-4791158-A Thermoplastic molding materials containing a polyester and a polycarbonate BASF AKTIENGESELLSCHAFT (DE) 1988-12-13 US claimed
EP-0034279-B1 SULFOALKYLATING AGENTS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN THE MANUFACTURE OF QUANTERNARY SULFOALKYL SALTS Agfa-Gevaert AG (DE) 1983-06-22 EP claimed
US-4145264-A AROMATIC O-DICARBOXYLIC ACID NITRILES ELECTROLYZED IN AN ORGANIC LIQUID WITH AN ALKALINE ACTIVATOR BASF AKTIENGESELLSCHAFT (DE) 1979-03-20 US claimed